Impact of recipient ACE I/D genotype on kidney function in renal transplant patients: a meta-analysis of cross-sectional and longitudinal studies

Pharmacogenomics. 2015 Nov;16(16):1887-902. doi: 10.2217/pgs.15.119. Epub 2015 Nov 11.

Abstract

Aim: To perform a systematic review and meta-analysis of studies evaluating the influence of recipient angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism on kidney function in renal transplant recipients.

Materials & methods: A comprehensive search was performed through PubMed, Web of Knowledge and Cochrane databases up to December 2014. The methodological quality of identified studies was assessed using the MINORS criteria.

Results: A total of 15 studies evaluating the role of recipient ACE I/D were included in the meta-analysis. In overall analyzes and subsequent subgroup and sensitivity analyzes, no evidence emerged of an effect of ACE I/D on serum creatinine levels, creatinine clearance or glomerular filtration rate.

Conclusion: Although further investigation is still needed to determine the role of donor ACE genotype, recipient ACE I/D does not play a significant role on kidney function in renal transplant patients.

Keywords: ACE; allograft dysfunction; meta-analysis; polymorphisms; renal transplantation.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Cross-Sectional Studies
  • Genotype*
  • Humans
  • Kidney / physiology*
  • Kidney Transplantation* / trends
  • Longitudinal Studies
  • Peptidyl-Dipeptidase A / genetics*
  • Transplant Recipients*

Substances

  • ACE protein, human
  • Peptidyl-Dipeptidase A